The success of this work could also provide an important foundation for a cellular model to investigate the pathogenesis of PD when patient skin fibroblasts are reprogrammed into iDPs with Brn2, Sox2 and Foxa2 in vitro. The gene discussed is FOXA2; the disease is Parkinson disease.